Skip to main content
    P

    Pro-Dex Inc (PDEX)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $60.02
    +0.20 (+0.33%)

    Market Cap: $203.99M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    72%(28/39)
    Avg Surprise
    +94.24%
    Streak
    4 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.67
    Range$0.67 - $0.67
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.66+1.5%
    60d ago$0.66+1.5%
    30d ago$0.66+1.5%
    7d ago$0.66+1.5%
    Current$0.67
    Revenue Consensus
    $20M
    Range$20M - $20M
    1 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.72
    Range$0.72 - $0.72
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.69+4.3%
    60d ago$0.69+4.3%
    30d ago$0.69+4.3%
    7d ago$0.69+4.3%
    Current$0.72
    Revenue Consensus
    $21M
    Range$21M - $21M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.72---
    Sep 26EST
    		-$0.67---
    Jun 26
    Reported Sep 3
    		$0.87$0.67+29.85%Beat+141.7%
    Mar 26
    Reported Apr 30
    		$1.20$0.62+93.55%Beat+41.2%
    Dec 25
    Reported Jan 29
    		$0.66$0.59+12.19%Beat+8.5%
    Sep 25
    Reported Oct 30
    		$1.40$0.50+180.00%Beat+86.7%
    Jun 25
    Reported Sep 4
    		$0.36$0.47-23.40%Miss-21.7%
    Mar 25
    Reported May 1
    		$0.85$0.47+80.85%Beat+347.4%
    Dec 24
    Reported Jan 30
    		$0.61$0.38+60.53%Beat+335.7%
    Sep 24
    Reported Oct 31
    		$0.75$0.29+158.62%Beat+541.2%
    Jun 24
    Reported Sep 5
    		$0.46$0.35+31.43%Beat+9.5%
    Mar 24
    Reported May 2
    		$0.19$0.35-45.71%Miss-47.2%
    Dec 23
    Reported Feb 8
    		$0.14N/A-60.00%Miss-41.7%
    Sep 23
    Reported Oct 13
    		$-0.17$0.32-153.13%Miss-158.6%
    Jun 23
    Reported Sep 29
    		$0.42$0.33+27.27%Beat+10.5%
    Mar 23
    Reported May 4
    		$0.36$0.26+38.46%Beat+176.9%
    Dec 22
    Reported Feb 2
    		$0.24$0.29-17.24%Miss-4.0%
    Sep 22
    Reported Nov 3
    		$0.29$0.33-12.12%Miss+3.6%
    Jun 22
    Reported Aug 25
    		$0.38$0.18+111.11%Beat+72.7%
    Mar 22
    Reported May 5
    		$0.13N/A-60.61%Miss-74.0%
    Dec 21
    Reported Feb 3
    		$0.25$0.28-10.71%Miss+212.5%
    Sep 21
    Reported Nov 15
    		$0.28$0.28+0.00%Beat-12.5%
    Jun 21
    Reported Aug 26
    		$0.22$0.29-24.14%Miss-65.1%
    Mar 21
    Reported May 6
    		$0.50$0.22+127.27%Beat+66.7%
    Dec 20
    Reported Feb 4
    		$0.08N/A-77.14%Miss-74.2%
    Sep 20
    Reported Nov 5
    		$0.32$0.33-3.03%Miss+18.5%
    Jun 20
    Reported Aug 27
    		$0.63$0.18+250.00%Beat+200.0%
    Mar 20
    Reported May 7
    		$0.30$0.22+36.36%Beat+76.5%
    Dec 19
    Reported Feb 6
    		$0.31$0.22+40.91%Beat+40.9%
    Sep 19
    Reported Nov 7
    		$0.27$0.27+0.00%Beat-12.9%
    Jun 19
    Reported Aug 29
    		$0.21$0.12+75.00%Beat-4.5%
    Mar 19
    Reported May 9
    		$0.17$0.13+30.77%Beat+54.5%
    Dec 18
    Reported Feb 7
    		$0.22$0.10+120.00%Beat+83.3%
    Sep 18
    Reported Nov 8
    		$0.31$0.13+138.46%Beat+106.7%
    Jun 18
    Reported Sep 13
    		$0.22$0.06+266.67%Beat+22.2%
    Mar 18
    Reported May 10
    		$0.11$0.05+120.00%Beat-35.3%
    Dec 17
    Reported Feb 8
    		$0.12$0.04+200.00%Beat-84.4%
    Sep 17
    Reported Nov 9
    		$0.15$0.08+87.50%Beat-
    Jun 17
    Reported Sep 5
    		$0.18$0.02+800.00%Beat-
    Mar 17
    Reported May 11
    		$0.17$0.06+183.33%Beat-
    Dec 16
    Reported Feb 9
    		$0.77$0.08+862.50%Beat-

    Key Metrics

    Valuation
    P/E Ratio14.53EV/EBITDA11.50x
    Price/FCF28.65xFCF Yield3.49%
    Profitability
    Profit Margin17.60%Operating Margin17.30%
    ROE32.40%ROIC18.98%
    Financial Health
    Debt/Equity0.37xInterest Coverage20.06x
    Current Ratio4.10xQuick Ratio2.45x
    Trading Statistics
    Beta0.04Avg Volume58.69K
    52-Week High$77.0052-Week Low$23.47

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$62.71
    SMA 20$66.87
    SMA 50$66.11
    SMA 200$55.44
    EMA 10$62.87
    EMA 20$64.61
    EMA 50$64.89
    EMA 200$57.69

    MACD

    Line: -1.63Signal: -0.67Hist: -0.96

    ADX

    ADX: 20.8+DI: 13.5-DI: 28.0

    Aroon & PSAR

    Aroon Up44.0
    Aroon DownN/A
    PSAR$68.16

    Bollinger Bands

    Upper Band$76.32
    Lower Band$57.41
    %B Position2829%(Upper)
    Band Width0.14

    RSI (14-Day)

    Neutral
    36.5

    Momentum Oscillators

    Stoch %K6.9
    Stoch %D11.0
    Williams %R-93.7
    ROC (10d)-8.2%
    Momentum-5.34
    CCI (20d)-113.0
    MFI (14d)19.1

    Volatility Measures

    ATR (14d)$3.02(5.0%)
    StdDev (20d)4.73
    Hist Vol34.4%(Moderate)

    Volume Flow

    VWAP$60.05
    OBV-114.0K
    AD Line-847.0K
    CMF (20d)-0.131

    Volume Metrics

    Avg Vol (20d)56.5K
    Vol Ratio0.6x
    VWMA (20d)$67.64

    Pivot Points

    R3$65.04
    R2$63.90
    R1$61.86
    Pivot Point$60.71
    S1$58.67
    S2$57.53
    S3$55.49

    Advanced Oscillators

    TSI-13.78
    Ultimate Osc34.8
    KST-46.62

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$20.41M$19.95M$18.66M$18.53M$17.49M$17.41M$16.79M$14.89M$15.03M$14.29M$12.59M$11.94M
    Cost of Revenue$13.31M$13.82M$12.92M$13.16M$14.00M$11.62M$11.72M$9.74M$10.94M$10.29M$9.79M$8.28M
    Gross Profit$7.09M$6.13M$5.74M$5.37M$3.49M$5.80M$5.07M$5.15M$4.09M$4.00M$2.80M$3.66M
    Operating Expenses$3.56M$3.04M$2.48M$2.26M$2.15M$2.16M$2.38M$2.14M$1.74M$1.79M$2.02M$1.82M
    R&D$1.02M$827,000$734,000$768,000$904,000$947,000$942,000$843,000$836,000$760,000$788,000$805,000
    SG&A$2.55M$2.21M$1.75M$1.49M$1.24M$1.21M$1.44M$1.29M$903,000$1.03M$1.24M$1.02M
    Operating Income$3.53M$3.09M$3.26M$3.11M$1.34M$3.64M$2.69M$3.01M$2.35M$2.21M$777,000$1.83M
    Interest Income$3.56M$2.45M$-190,000$14,000$-570,000$1.16M$98,000$25,000$1.35M$-1,192,000$-40,000$24,000
    Interest Expense$270,000$201,000$141,000$200,000$227,000$246,000$204,000$152,000$148,000$138,000$139,000$133,000
    Income Before Tax$3.52M$5.34M$2.93M$6.22M$1.60M$4.55M$2.59M$3.32M$1.93M$913,000$620,000$-829,000
    Income Tax Expense$668,000$1.40M$741,000$1.54M$402,000$1.28M$546,000$853,000$343,000$258,000$120,000$-214,000
    Net Income$2.86M$3.94M$2.19M$4.68M$1.20M$3.27M$2.04M$2.47M$1.59M$655,000$500,000$-615,000
    EBITDA$3.95M$3.40M$3.58M$6.72M$1.64M$3.93M$3.01M$3.76M$1.04M$2.51M$1.08M$-433,000
    EBIT$3.53M$3.09M$3.26M$6.41M$1.34M$3.64M$2.69M$3.45M$726,000$2.24M$799,000$-720,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PDEX

    News

    Pro Dex CEO Richard Van Kirk sells $45,412 in PDEX stock By Investing.com

    Pro Dex CEO Richard Van Kirk sold $45,412 worth of company common stock on September 11, 2026, through two separate transactions under a Rule 10b5-1 trading plan. The sales occurred at prices ranging from $58.36...

    Investing.com South Africa•9/16/26•Somewhat-Bearish

    Pro Dex CEO Richard Van Kirk sells $45,412 in PDEX stock

    Pro Dex CEO Richard Van Kirk sold $45,412 worth of PDEX common stock on September 11, 2026, through two transactions executed under a Rule 10b5-1 trading plan. The sales occurred at prices ranging from $58.36 to $59.91...

    Investing.com India•9/14/26•Somewhat-Bearish

    Pro-dex CFO Alisha Charlton sells $140,983 in company stock

    Alisha Charlton, CFO of Pro-dex (NASDAQ:PDEX), sold 2,300 shares of company stock for approximately $140,983 on September 9, 2026. The shares were sold at prices ranging from $61.05 to $61.76. Following the transactions...

    Investing.com India•9/11/26•Somewhat-Bearish

    Pro-dex CEO Richard Van Kirk sells $1.16m in company stock

    Pro-dex CEO Richard Van Kirk sold 19,235 shares of PRO DEX INC (NASDAQ:PDEX) stock for a total of $1,165,289. The sales were executed under a Rule 10b5-1 trading plan and occurred after the stock saw significant gains....

    Investing.com Canada•9/11/26•Somewhat-Bearish

    Pro-dex CEO Richard Van Kirk sells $1.16m in company stock

    Richard Lee Van Kirk Jr., CEO of PRO DEX INC (NASDAQ:PDEX), sold 19,235 shares of the company's common stock for $1,165,289 on September 9, 2026...

    Investing.com Australia•9/11/26•Somewhat-Bearish

    PDEX Valuation and Fair Value

    P/E
    14.5x
    Forward P/E
    23.4x
    EV/EBITDA
    11.5x
    P/FCF
    28.6x
    PEG
    0.0x
    P/B
    4.1x
    See GNG's fair value

    PDEX Profitability: Margins, ROIC and FCF

    Gross margin
    31.4%
    Operating margin
    17.3%
    Net margin
    17.6%
    ROIC
    19.0%
    ROE
    32.4%
    FCF margin
    8.7%
    FCF yield
    3.5%

    PDEX Competitors

    CompanyTicker
    Cartesian Therapeutics Inc.RNAC
    Exagen IncXGN
    ProQR Therapeutics BVPRQR
    Cybin IncCYBN
    Alector IncALEC
    Niagen Bioscience, Inc.NAGE
    Protalix Biotherapeutics IncPLX
    Akebia TherAKBA

    Sector: Healthcare

    PDEX Bull Case vs Bear Case

    Bull case

    • PDEX earns a 19.0% return on invested capital.
    • PDEX beat EPS estimates in 87.5% of its last 8 reported quarters.
    • PDEX grew quarterly revenue 16.6% year over year.

    PDEX Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    74.0%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.67
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    Frequently Asked Questions About PDEX

    Does PDEX pay dividends?

    Pro-Dex Inc (PDEX) does not currently pay a regular dividend.

    What is PDEX's P/E ratio?

    Pro-Dex Inc has a price-to-earnings (P/E) ratio of 14.53.

    What is PDEX's market cap?

    Pro-Dex Inc (PDEX) has a market capitalization of $203.99M with a current stock price of $60.02.

    Related stocks

    Sector: Healthcare

    All stocks starting with P

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In